NCT04265976

Brief Summary

This study evaluate the 1-month mortality of patients who proceed a blood sample while in the ED with an hypernatremia (\>145 mmol/l). This prospective study will try to show several prognostic factors, and show the epidemiology of hypernatremia in this single center evaluation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 26, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 12, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

February 17, 2020

Status Verified

February 1, 2020

Enrollment Period

9 months

First QC Date

February 10, 2020

Last Update Submit

February 13, 2020

Conditions

Hypernatremia

Outcome Measures

Primary Outcomes (1)

  • one month survival

    Survival at 1 month after the blood sample at the ED

    1 month

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Every \>18 years old patient from who a blood sample was taken in the ED with a natremia \> 145 mmol/l and don't show a refusal after information.

You may qualify if:

  • Natremia \> 145 mmol/l

You may not qualify if:

  • Age \< 18 years
  • Refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Besançon

Besançon, 25000, France

RECRUITING

MeSH Terms

Conditions

Hypernatremia

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Romain ADAM, Resident

CONTACT

+33646470168radam@chu-besancon.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2020

First Posted

February 12, 2020

Study Start

August 26, 2019

Primary Completion

May 26, 2020

Study Completion

September 1, 2020

Last Updated

February 17, 2020

Record last verified: 2020-02

Locations

FR(1)